The Kappa Opioid Receptor: From Addiction to Depression, and Back
Tóm tắt
Từ khóa
Tài liệu tham khảo
Volkow, 2011, Addiction: pulling at the neural threads of social behaviors, Neuron, 69, 599, 10.1016/j.neuron.2011.01.027
Bakken, 2007, Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients, BMC Psychiatry, 7, 29, 10.1186/1471-244X-7-29
de Graaf, 2004, Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study, J Affect Disord, 82, 461, 10.1016/j.jad.2004.03.001
Goldstein, 1979, Dynorphin-(1-13), an extraordinarily potent opioid peptide, Proc Natl Acad Sci U S A, 76, 6666, 10.1073/pnas.76.12.6666
Chavkin, 1982, Dynorphin is a specific endogenous ligand of the kappa opioid receptor, Science, 215, 413, 10.1126/science.6120570
Le Merrer, 2009, Reward processing by the opioid system in the brain, Physiol Rev, 89, 1379, 10.1152/physrev.00005.2009
Nestler, 2005, Is there a common molecular pathway for addiction?, Nat Neurosci, 8, 1445, 10.1038/nn1578
Pradhan, 2011, The delta opioid receptor: an evolving target for the treatment of brain disorders, Trends Pharmacol Sci, 32, 581, 10.1016/j.tips.2011.06.008
Lutz, 2013, The multiple facets of opioid receptor function: implications for addiction, Curr Opin Neurobiol, 23, 473, 10.1016/j.conb.2013.02.005
Lutz, 2013, Opioid receptors: distinct roles in mood disorders, Trends Neurosci, 36, 195, 10.1016/j.tins.2012.11.002
Charbogne, 2014, 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse, Neuropharmacology, 76, 204, 10.1016/j.neuropharm.2013.08.028
Chefer, 2013, Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion, Neuropsychopharmacology, 38, 2623, 10.1038/npp.2013.171
Tejeda, 2013, Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion, Neuropsychopharmacology, 38, 1770, 10.1038/npp.2013.76
Bruchas, 2011, Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction, Neuron, 71, 498, 10.1016/j.neuron.2011.06.011
Ahmad, 2013, Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus mu-opiate receptor dependent mechanisms, J Neurosci, 33, 15642, 10.1523/JNEUROSCI.1686-13.2013
Schindler, 2012, Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake, J Neurosci, 32, 17582, 10.1523/JNEUROSCI.3220-12.2012
Bruchas, 2010, The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors, Brain Res, 1314, 44, 10.1016/j.brainres.2009.08.062
Berger, 2013, Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors, Neuropsychopharmacology, 38, 647, 10.1038/npp.2012.229
Smith, 2012, Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference, J Neurosci, 32, 1488, 10.1523/JNEUROSCI.2980-11.2012
Kallupi, 2013, Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction, Biol Psychiatry, 74, 520, 10.1016/j.biopsych.2013.04.028
Harrison, 2013, Trial watch: opioid receptor blocker shows promise in phase II depression trial, Nat Rev Drug Discov, 12, 415, 10.1038/nrd4028
Gerra, 2004, Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome, Drug Alcohol Depend, 75, 37, 10.1016/j.drugalcdep.2003.11.017
Gerra, 2006, Naltrexone and buprenorphine combination in the treatment of opioid dependence, J Psychopharmacol, 20, 806, 10.1177/0269881106060835
Pfeiffer, 1986, Psychotomimesis mediated by kappa opiate receptors, Science, 233, 774, 10.1126/science.3016896
Roth, 2002, Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist, Proc Natl Acad Sci U S A, 99, 11934, 10.1073/pnas.182234399
Shippenberg, 1986, Differential effects of mu and kappa opioid systems on motivational processes, NIDA Res Monogr, 75, 563
Nestler, 2006, The mesolimbic dopamine reward circuit in depression, Biol Psychiatry, 59, 1151, 10.1016/j.biopsych.2005.09.018
Di Chiara, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc Natl Acad Sci U S A, 85, 5274, 10.1073/pnas.85.14.5274
Johnson, 1992, Opioids excite dopamine neurons by hyperpolarization of local interneurons, J Neurosci, 12, 483, 10.1523/JNEUROSCI.12-02-00483.1992
Jalabert, 2011, Neuronal circuits underlying acute morphine action on dopamine neurons, Proc Natl Acad Sci U S A, 108, 16446, 10.1073/pnas.1105418108
Matsui, 2014, Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal, Neuron, 82, 1346, 10.1016/j.neuron.2014.04.030
Spanagel, 1992, Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway, Proc Natl Acad Sci U S A, 89, 2046, 10.1073/pnas.89.6.2046
Metzger, 2001, Site- and time-specific gene targeting in the mouse, Methods, 24, 71, 10.1006/meth.2001.1159
Backman, 2006, Characterization of a mouse strain expressing Cre recombinase from the 3’ untranslated region of the dopamine transporter locus, Genesis, 44, 383, 10.1002/dvg.20228
Paterson, 2007, Animal models and treatments for addiction and depression co-morbidity, Neurotox Res, 11, 1, 10.1007/BF03033479
Land, 2008, The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system, J Neurosci, 28, 407, 10.1523/JNEUROSCI.4458-07.2008
Land, 2009, Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking, Proc Natl Acad Sci U S A, 106, 19168, 10.1073/pnas.0910705106
Al-Hasani, 2013, Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism, Neuropsychopharmacology, 38, 2484, 10.1038/npp.2013.151
Lemos, 2012, Repeated stress dysregulates kappa-opioid receptor signaling in the dorsal raphe through a p38alpha MAPK-dependent mechanism, J Neurosci, 32, 12325, 10.1523/JNEUROSCI.2053-12.2012
Beardsley, 2005, Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats, Psychopharmacology, 183, 118, 10.1007/s00213-005-0167-4
Mague, 2003, Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats, J Pharmacol Exp Ther, 305, 323, 10.1124/jpet.102.046433
Shirayama, 2004, Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects, J Neurochem, 90, 1258, 10.1111/j.1471-4159.2004.02589.x
Carlezon, 2006, Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats, J Pharmacol Exp Ther, 316, 440, 10.1124/jpet.105.092304
Falcon, 2014, Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice, Psychopharmacology, 10.1007/s00213-014-3723-y
Cohen, 2014, Virus-mediated shRNA knockdown of prodynorphin in the rat nucleus accumbens attenuates depression-like behavior and cocaine locomotor sensitization, PLoS One, 9, e97216, 10.1371/journal.pone.0097216
Muschamp, 2014, Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area, Proc Natl Acad Sci U S A, 111, E1648, 10.1073/pnas.1315542111
Li, 2014, Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation, Proc Natl Acad Sci U S A, 111, 5765, 10.1073/pnas.1403603111
Bals-Kubik, 1993, Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J Pharmacol Exp Ther, 264, 489
Svingos, 2001, Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles, Synapse, 42, 185, 10.1002/syn.10005
Meshul, 2000, Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons, Neuroscience, 96, 91, 10.1016/S0306-4522(99)90481-5
Hjelmstad, 2003, Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms, J Neurophysiol, 89, 2389, 10.1152/jn.01115.2002
Svingos, 2002, Kappa-opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex, Brain Res, 946, 262, 10.1016/S0006-8993(02)02894-9
Margolis, 2003, Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons, J Neurosci, 23, 9981, 10.1523/JNEUROSCI.23-31-09981.2003
Margolis, 2006, Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex, Proc Natl Acad Sci U S A, 103, 2938, 10.1073/pnas.0511159103
Ekstrand, 2014, Molecular profiling of neurons based on connectivity, Cell, 157, 1230, 10.1016/j.cell.2014.03.059
Erbs, 2014, A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks, Brain Struct Funct, 10.1007/s00429-014-0717-9
Scherrer, 2006, Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo, Proc Natl Acad Sci U S A, 103, 9691, 10.1073/pnas.0603359103
Wee, 2010, The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse, Psychopharmacology, 210, 121, 10.1007/s00213-010-1825-8
Kuzmin, 1997, Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice, Eur J Pharmacol, 321, 265, 10.1016/S0014-2999(96)00961-2
Glick, 1995, Kappa opioid inhibition of morphine and cocaine self-administration in rats, Brain Res, 681, 147, 10.1016/0006-8993(95)00306-B
Nestby, 1999, Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference, Psychopharmacology, 142, 309, 10.1007/s002130050894
Lindholm, 2001, The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat, Behav Brain Res, 120, 137, 10.1016/S0166-4328(00)00368-5
Logrip, 2009, Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H, Alcohol, 43, 359, 10.1016/j.alcohol.2009.05.001
Negus, 1997, Effects of kappa opioids on cocaine self-administration by rhesus monkeys, J Pharmacol Exp Ther, 282, 44
Mello, 1998, Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys, J Pharmacol Exp Ther, 286, 812
Schenk, 2001, Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration, Neuropsychopharmacology, 24, 441, 10.1016/S0893-133X(00)00190-1
Schenk, 1999, U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking, Psychopharmacology, 144, 339, 10.1007/s002130051016
Galeote, 2009, Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice, Int J Neuropsychopharmacol, 12, 615, 10.1017/S1461145708009450
Mendizabal, 2006, Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice, Neuropsychopharmacology, 31, 1957, 10.1038/sj.npp.1300957
Maisonneuve, 1994, U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats, Neurosci Lett, 181, 57, 10.1016/0304-3940(94)90559-2
Femenia, 2011, Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission, Addict Biol, 17, 322, 10.1111/j.1369-1600.2011.00378.x
Resendez, 2012, Kappa-opioid receptors within the nucleus accumbens shell mediate pair bond maintenance, J Neurosci, 32, 6771, 10.1523/JNEUROSCI.5779-11.2012
Vanderschuren, 1995, Mu- and kappa-opioid receptor-mediated opioid effects on social play in juvenile rats, Eur J Pharmacol, 276, 257, 10.1016/0014-2999(95)00040-R
Trezza, 2010, The pleasures of play: pharmacological insights into social reward mechanisms, Trends Pharmacol Sci, 31, 463, 10.1016/j.tips.2010.06.008
Robles, 2014, Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females, Behav Brain Res, 262, 84, 10.1016/j.bbr.2014.01.003
Carlezon, 2007, Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation, Nat Protoc, 2, 2987, 10.1038/nprot.2007.441
Todtenkopf, 2004, Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats, Psychopharmacology, 172, 463, 10.1007/s00213-003-1680-y
Potter, 2011, Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity, Biol Psychiatry, 70, 744, 10.1016/j.biopsych.2011.05.021
Solomon, 1973, An opponent-process theory of motivation. II Cigarette addiction, J Abnorm Psychol, 81, 158, 10.1037/h0034534
Koob, 2008, Review. Neurobiological mechanisms for opponent motivational processes in addiction, Philos Trans R Soc Lond B Biol Sci, 363, 3113, 10.1098/rstb.2008.0094
Thompson, 2000, Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine, J Neurosci, 20, 9333, 10.1523/JNEUROSCI.20-24-09333.2000
Ebner, 2010, Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens, Psychopharmacology, 210, 241, 10.1007/s00213-010-1836-5
Gehrke, 2008, Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum, Psychopharmacology, 197, 509, 10.1007/s00213-007-1067-6
Zhang, 2005, Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors, Psychopharmacology, 179, 551, 10.1177/0269881105056526
Muschamp, 2011, Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats, J Neurosci, 31, 3095, 10.1523/JNEUROSCI.5973-10.2011
Russell, 2014, Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist u-50488 in rats, Biol Psychiatry, 76, 213, 10.1016/j.biopsych.2013.07.042
Newton, 2002, Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect, J Neurosci, 22, 10883, 10.1523/JNEUROSCI.22-24-10883.2002
del Rosario Capriles, 2002, Motivational effects mu- and kappa-opioid agonists following acute and chronic restraint stress: involvement of dopamine D(1) and D(2) receptors, Behav Brain Res, 132, 159, 10.1016/S0166-4328(01)00414-4
McLaughlin, 2003, Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses, J Neurosci, 23, 5674, 10.1523/JNEUROSCI.23-13-05674.2003
Miczek, 2008, Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake, Pharmacol Ther, 120, 102, 10.1016/j.pharmthera.2008.07.006
McLaughlin, 2006, Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system, Neuropsychopharmacology, 31, 1241, 10.1038/sj.npp.1300872
Krishnan, 2007, Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions, Cell, 131, 391, 10.1016/j.cell.2007.09.018
Berube, 2013, Enkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stress, Physiol Behav, 122, 237, 10.1016/j.physbeh.2013.04.009
Nocjar, 2012, The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus, Neuroscience, 218, 138, 10.1016/j.neuroscience.2012.05.033
Chaudhury, 2013, Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons, Nature, 493, 532, 10.1038/nature11713
Tao, 2002, Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system, J Pharmacol Exp Ther, 303, 549, 10.1124/jpet.102.037861
Tao, 2005, mu-opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus, Brain Res, 1049, 70, 10.1016/j.brainres.2005.04.076
Zhang, 2007, Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies, Eur J Pharmacol, 570, 89, 10.1016/j.ejphar.2007.05.045
Sinha, 2006, Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes, Arch Gen Psychiatry, 63, 324, 10.1001/archpsyc.63.3.324
Aldrich, 2009, Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action, Proc Natl Acad Sci U S A, 106, 18396, 10.1073/pnas.0910180106
Redila, 2008, Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system, Psychopharmacology, 200, 59, 10.1007/s00213-008-1122-y
McLaughlin, 2006, Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning, Neuropsychopharmacology, 31, 787, 10.1038/sj.npp.1300860
Sperling, 2010, Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration, Psychopharmacology, 210, 199, 10.1007/s00213-010-1844-5
Kreibich, 2008, Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system, J Neurosci, 28, 6516, 10.1523/JNEUROSCI.0390-08.2008
Reyes, 2009, Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus, J Comp Neurol, 512, 419, 10.1002/cne.21880
Zhou, 2013, Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats, Synapse, 67, 358, 10.1002/syn.21638
Lutz, 2013, Multiple serotonergic paths to antidepressant efficacy, J Neurophysiol, 109, 2245, 10.1152/jn.01093.2012
McDevitt, 2011, Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective, J Chem Neuroanat, 41, 234, 10.1016/j.jchemneu.2011.05.001
Graziane, 2013, Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity, Neuron, 77, 942, 10.1016/j.neuron.2012.12.034
Polter, 2014, Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking, Biol Psychiatry, 10.1016/j.biopsych.2014.04.019
Sivam, 1989, Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism, J Pharmacol Exp Ther, 250, 818
Solecki, 2009, Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration, Brain Res, 1255, 113, 10.1016/j.brainres.2008.12.002
Przewlocka, 1997, Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens, Neurosci Lett, 238, 13, 10.1016/S0304-3940(97)00829-X
Lindholm, 2000, Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain, Alcohol, 22, 165, 10.1016/S0741-8329(00)00118-X
D’Addario, 2013, Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain, Addict Biol, 18, 425, 10.1111/j.1369-1600.2011.00326.x
Muschamp, 2013, Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation, Cold Spring Harb Perspect Med, 3, a012005, 10.1101/cshperspect.a012005
Bazov, 2013, The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction, Addict Biol, 18, 161, 10.1111/j.1369-1600.2011.00366.x
Rassnick, 1993, Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal, Brain Res, 605, 25, 10.1016/0006-8993(93)91352-S
Rasmussen, 2001, Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence, Alcohol Clin Exp Res, 25, 999, 10.1111/j.1530-0277.2001.tb02308.x
Valdez, 2004, Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation, Alcohol Clin Exp Res, 28, 865, 10.1097/01.ALC.0000128222.29875.40
Valdez, 2003, Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence, Alcohol, 29, 55, 10.1016/S0741-8329(03)00020-X
Valdez, 2012, kappa opioid regulation of anxiety-like behavior during acute ethanol withdrawal, Pharmacol Biochem Behav, 102, 44, 10.1016/j.pbb.2012.03.019
Williams, 2012, The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in Wistar rats, Psychopharmacology, 223, 75, 10.1007/s00213-012-2691-3
Kessler, 2012, Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the national comorbidity survey replication adolescent supplement, Arch Gen Psychiatry, 69, 372, 10.1001/archgenpsychiatry.2011.160
Barnett, 2012, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, 380, 37, 10.1016/S0140-6736(12)60240-2
Cerda, 2008, Comorbid forms of psychopathology: key patterns and future research directions, Epidemiol Rev, 30, 155, 10.1093/epirev/mxn003
Kissler, 2014, The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors, Biol Psychiatry, 75, 774, 10.1016/j.biopsych.2013.03.014
Wright, 2011, Toward affective circuit-based preclinical models of depression: sensitizing dorsal PAG arousal leads to sustained suppression of positive affect in rats, Neurosci Biobehav Rev, 35, 1902, 10.1016/j.neubiorev.2011.08.004
Milligan, 2003, Principles: extending the utility of [35S]GTP gamma S binding assays, Trends Pharmacol Sci, 24, 87, 10.1016/S0165-6147(02)00027-5
Kang-Park, 2013, kappa-opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic Sites, J Pharmacol Exp Ther, 346, 130, 10.1124/jpet.112.202903
Kenny, 2006, Conditioned withdrawal drives heroin consumption and decreases reward sensitivity, J Neurosci, 26, 5894, 10.1523/JNEUROSCI.0740-06.2006
Gillett, 2013, Protracted withdrawal from ethanol and enhanced responsiveness stress: Regulation via the dynorphin/kappa opioid receptor system, Alcohol, 47, 359, 10.1016/j.alcohol.2013.05.001
Goeldner, 2011, Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine, Biol Psychiatry, 69, 236, 10.1016/j.biopsych.2010.08.021
Lutz, 2013, A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice, Behav Brain Res, 243, 44, 10.1016/j.bbr.2012.12.049
Lutz, 2011, Sequential and opposing alterations of 5-HT(1A) receptor function during withdrawal from chronic morphine, Eur Neuropsychopharmacol, 21, 835, 10.1016/j.euroneuro.2011.02.002
Lutz, 2014, Distinct mu, delta and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence, Neuropsychopharmacology, 39, 2694, 10.1038/npp.2014.126
Belin, 2008, High impulsivity predicts the switch to compulsive cocaine-taking, Science, 320, 1352, 10.1126/science.1158136
Deroche-Gamonet, 2004, Evidence for addiction-like behavior in the rat, Science, 305, 1014, 10.1126/science.1099020
Spetea, 2013, Current kappa opioid receptor ligands and discovery of a new molecular scaffold as a kappa opioid receptor antagonist using pharmacophore-based virtual screening, Curr Pharm Des, 19, 7362, 10.2174/138161281942140105162601
Dean, 2004, Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence, Eur Psychiatry, 19, 510, 10.1016/j.eurpsy.2004.09.002
Rorick-Kehn, 2014, LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders, Neuropharmacology, 77, 131, 10.1016/j.neuropharm.2013.09.021
Urbano, 2014, Antagonists of the kappa opioid receptor, Bioorg Med Chem Lett, 24, 2021, 10.1016/j.bmcl.2014.03.040
Carroll, 2013, Development of kappa opioid receptor antagonists, J Med Chem, 56, 2178, 10.1021/jm301783x
Melief, 2011, Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation, Mol Pharmacol, 80, 920, 10.1124/mol.111.074195
Melief, 2010, Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling, Proc Natl Acad Sci U S A, 107, 11608, 10.1073/pnas.1000751107
Pradhan, 2012, Ligand-directed signalling within the opioid receptor family, Br J Pharmacol, 167, 960, 10.1111/j.1476-5381.2012.02075.x
Al-Hasani, 2011, Molecular mechanisms of opioid receptor-dependent signaling and behavior, Anesthesiology, 115, 1363, 10.1097/ALN.0b013e318238bba6
Schattauer, 2012, Ligand directed signaling differences between rodent and human kappa-opioid receptors, J Biol Chem, 287, 41595, 10.1074/jbc.M112.381368
Wang, 2014, The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance, J Clin Psychopharmacol, 34, 205, 10.1097/JCP.0000000000000082
Nielsen, 2013, The kappa-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial, Psychiatr Genet, 23, 225, 10.1097/YPG.0000000000000008
Gerra, 2014, Association between gene variants and response to buprenorphine maintenance treatment, Psychiatry Res, 215, 202, 10.1016/j.psychres.2013.11.001
Zheng, 2013, Synthesis and evaluation of 11C-LY2795050 as a kappa-opioid receptor antagonist radiotracer for PET imaging, J Nucl Med, 54, 455, 10.2967/jnumed.112.109512
Markou, 1998, Neurobiological similarities in depression and drug dependence: a self-medication hypothesis, Neuropsychopharmacology, 18, 135, 10.1016/S0893-133X(97)00113-9
Hill, 2012, Neurobiology of chronic mild stress: parallels to major depression, Neurosci Biobehav Rev, 36, 2085, 10.1016/j.neubiorev.2012.07.001
Willner, 2005, Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS, Neuropsychobiology, 52, 90, 10.1159/000087097
Bambico, 2013, Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis?, Curr Top Behav Neurosci, 15, 243, 10.1007/7854_2012_234
Papp, 1991, An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress, Psychopharmacology, 104, 255, 10.1007/BF02244188
Valverde, 1997, The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist, Psychopharmacology, 131, 79, 10.1007/s002130050268
Al-Hasani, 2013, Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference, Front Pharmacol, 4, 96, 10.3389/fphar.2013.00096
Lanteri, 2014, Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons, Mol Psychiatry, 19, 823, 10.1038/mp.2013.97
Tassin, 2008, Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse, Biochem Pharmacol, 75, 85, 10.1016/j.bcp.2007.06.038